CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0044-1786002
Original Article

Comparative Analysis of Surgical Site Infections in Pediatric Brain Tumor Patients: Hygiene Practices, Risk Factors, and Implications for Healthcare Costs and Mortality

1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
,
Muhammad Sohaib Shahid
2   Medical College, Aga Khan University, Karachi, Pakistan
,
Naureen Mushtaq
1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
,
Hira Saleem
1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
,
Altaf Ali Laghari
3   Department of Surgery, Aga Khan University, Karachi, Pakistan
,
Zahra Saeed Ahmed
2   Medical College, Aga Khan University, Karachi, Pakistan
,
Shayan Anwar
4   Department of Radiology, Aga Khan University, Karachi, Pakistan
,
Farrah Bashir
1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
,
Zehra Fadoo
1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
,
Fatima Mir
5   Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan
,
Sadaf Altaf
1   Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan
› Author Affiliations
Funding None.

Abstract

Zoom Image
Syed Ibrahim Bukhari

Surgical site infections (SSIs) significantly impact pediatric central nervous system tumor outcomes. We present our data of SSIs and their influence on outcomes of pediatric brain tumor patients treated between January 2011 till December 2022. This study utilized retrospective data from patients' medical records. Chi-squared test was used for correlational analysis. Independent sample t-test was used for equality of means. Linear and logistic regression was done to review impact of independent variables on dependent variable. Survival analysis was done using Kaplan–Meier curves. Between 2011 and 2022, 336 pediatric patients (202 males, 134 females) were diagnosed with brain tumors. Majority patients (279; 83%) underwent surgery (91% elective). Commonest tumor site was cerebellum (84/279; 30%). Tumor resection status was gross total resection (29/279; 46%), subtotal resection (59/279; 21%), near total resection (48/279; 17%), and partial resection (20/279; 7%); while 32/279 patients (11%) had a biopsy only. Hydrocephalus was present in 166/279 patients (59%); while majority (160/166; 96%) underwent a cerebrospinal fluid (CSF) diversion procedure. SSI developed in 23/279 patients (8%), leading to delayed postoperative management in majority (15/23; 65%). SSIs were significantly associated with lower age of presentation (p = 0.01), less duration between symptoms and diagnosis (p = 0.00), performance of CSF diversion procedure (p = 0.04), increase in hospital stay (p = 0.00), delay in postoperative management (15/23; 65%) (p = 0.01), decline in treatment completion (p = 0.01), and poor survival (p = 0.01). Majority (171/279) of patients (61%) completed treatment. The overall survival of our cohort was 84.9% with a median follow-up time of 11 (interquartile range [IQR]: 36, 1) months. Survival was significantly lower (56.5%) in patients with SSI (p = 0.01). Median time to death was 18 months. Progression-free survival was 77.4% with a median progression-free time of 8 (IQR: 28, 1) months. Median time to progression was 9 (IQR: 24, 4.5) months. The incidence of SSIs in our cohort closely resembled that of high-income countries. Risk factors for SSIs included younger age, a shorter time between symptom onset and surgery, undertaking of CSF diversion procedures. Adverse effects of SSIs included increased costs, delays in postoperative management, incomplete treatment, and higher mortality rates. This study emphasizes the substantial impact of SSIs on healthcare resources and patient well-being.

Ethical Approval

Ethical review committee approval was obtained via letter number 2023-9316-26871, dated October 23rd, 2023.




Publication History

Article published online:
15 April 2024

© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Hossain MJ, Xiao W, Tayeb M, Khan S. Epidemiology and prognostic factors of pediatric brain tumor survival in the US: evidence from four decades of population data. Cancer Epidemiol 2021; 72: 101942
  • 2 Bhakta N, Force LM, Allemani C. et al. Childhood cancer burden: a review of global estimates. Lancet Oncol 2019; 20 (01) e42-e53
  • 3 Udaka YT, Packer RJ. Packer RJJNc. Pediatric brain tumors. Neurol Clin 2018; 36 (03) 533-556
  • 4 Bathla G, Policeni B, Hansen MR, Berbaum K. Calculating the tumor volumes in vestibular schwannomas: are the ABC/2 and volumetric methods comparable?. Otol Neurotol 2017; 38 (06) 889-894
  • 5 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
  • 6 Palombi L, Marchetti P, Salvati M, Osti MF, Frati L, Frati A. Interventions to reduce neurological symptoms in patients with GBM receiving radiotherapy: from theory to clinical practice. Anticancer Res 2018; 38 (04) 2423-2427
  • 7 Karschnia P, Vogelbaum MA, van den Bent M. et al. Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 2021; 149: 23-33
  • 8 Borchardt RA, Tzizik D. Update on surgical site infections: the new CDC guidelines. JAAPA 2018; 31 (04) 52-54
  • 9 Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23 (03) 467-492
  • 10 Kimberlin DW. Red Book: 2018–2021 report of the committee on infectious diseases. American Academy of Pediatrics; 2018
  • 11 Haque M, McKimm J, Godman B, Abu Bakar M, Sartelli M. Initiatives to reduce postoperative surgical site infections of the head and neck cancer surgery with a special emphasis on developing countries. Expert Rev Anticancer Ther 2019; 19 (01) 81-92
  • 12 Sattar F, Sattar Z, Zaman M, Akbar S. Frequency of post-operative surgical site infections in a Tertiary care hospital in Abbottabad, Pakistan. Cureus 2019; 11 (03) e4243
  • 13 Sáenz A, Badaloni E, Grijalba M, Villalonga JF, Argañaraz R, Mantese B. Risk factors for surgical site infection in pediatric posterior fossa tumors. Childs Nerv Syst 2021; 37 (10) 3049-3056
  • 14 Sneh-Arbib O, Shiferstein A, Dagan N. et al. Surgical site infections following craniotomy focusing on possible post-operative acquisition of infection: prospective cohort study. Eur J Clin Microbiol Infect Dis 2013; 32 (12) 1511-1516
  • 15 Lee RP, Venable GT, Vaughn BN, Lillard JC, Oravec CS, Klimo Jr P. The impact of a pediatric shunt surgery checklist on infection rate at a single institution. Neurosurgery 2018; 83 (03) 508-520
  • 16 Boethun A, Vissing NH, Mathiasen R, Skjøth-Rasmussen J, Foss-Skiftesvik J. CNS infection in children with brain tumors: adding ventriculostomy to brain tumor resection increases risk more than 20-fold. Childs Nerv Syst 2023; 39 (02) 387-394
  • 17 Alther B, Mylius V, Weller M, Gantenbein A. From first symptoms to diagnosis: Initial clinical presentation of primary brain tumors. Clin Transl Neusci 2020; 4 (02) 17 . Doi: 2514183X20968368
  • 18 Roth J, Constantini S. Hydrocephalus and brain tumors. Cerebrospinal Fluid Disorders SpringerLink; 2019
  • 19 Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States—an analysis based on timing of diagnosis and severity level. Crit Care Med 2018; 46 (12) 1889-1897
  • 20 Allegranzi B, Bischoff P, de Jonge S. et al; WHO Guidelines Development Group. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016; 16 (12) e276-e287